- Filed
- May 9, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 7, 2025 | 167.32M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $60.08M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $76.69M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $19.12M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $19.02M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $20.83M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $21.28M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $124.12M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $130.18M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $134.25M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $138.68M |
| Gross Profit | Q1 2025 · Mar 31, 2025 | $23.28M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $21.73M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2025 | $28.9M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $23.69M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 168.85M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $0 |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$3.39M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $119.58M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $118.65M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.01 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.01 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $5.2M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $3.74M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$1.47M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$1.68M |
| Revenue | Q1 2025 · Mar 31, 2024 | $45.42M |